Everett Harris & Co
- SEC CIK
- 0001009254
- Latest filing
- Aug 3, 2026
GSK holding history
GSK plc in every 13F filed by Everett Harris & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,853
- Value
- $306.8K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,853 | $306.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 5,853 | $323.0K | <0.1% | −800−12.0% | Reduced | Holders |
| Q4 2025 | 6,653 | $326.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 6,653 | $287.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 6,653 | $255.5K | <0.1% | −23−0.3% | Reduced | Holders |
| Q1 2025 | 6,676 | $258.6K | <0.1% | −720−9.7% | Reduced | Holders |
| Q4 2024 | 7,396 | $250.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 7,396 | $302.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 7,396 | $284.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 7,396 | $317.1K | <0.1% | −2,272−23.5% | Reduced | Holders |
| Q4 2023 | 9,668 | $358.3K | <0.1% | −503−4.9% | Reduced | Holders |
| Q3 2023 | 10,171 | $368.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,171 | $362.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,171 | $361.9K | <0.1% | −640−5.9% | Reduced | Holders |
| Q4 2022 | 10,811 | $380.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,811 | $318.0K | <0.1% | −2,735−20.2% | Reduced | Holders |
| Q2 2022 | 13,546 | $590.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 13,546 | $590.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 13,546 | $597.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 13,546 | $518.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 13,546 | $539.0K | <0.1% | −119−0.9% | Reduced | Holders |
| Q1 2021 | 13,665 | $488.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.